Immune regulatory mechanisms in ANCA-associated vasculitides

Autoimmunity Reviews

Volumn 11, Issue 2, 2011, Pages 77-83

  Lepse, Nikola ^a   Abdulahad, Wayel H ^a   Kallenberg, Cees G M ^a   Heeringa, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA; B cells; T cells; Vasculitides

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEPTIDOGLYCAN; REACTIVE OXYGEN METABOLITE; RITUXIMAB; SUPERANTIGEN; TUMOR NECROSIS FACTOR; EPITOPE;

ADAPTIVE IMMUNITY; ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; EFFECTOR CELL; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MEMORY CELL; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY B LYMPHOCYTE; REGULATORY T LYMPHOCYTE; REVIEW; STAPHYLOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TFH CELL; TH17 CELL; VASCULAR ENDOTHELIUM; WEGENER GRANULOMATOSIS; B LYMPHOCYTE; HELPER CELL; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; B-LYMPHOCYTES, REGULATORY; EPITOPES; GRANULOMA; HUMANS; INFLAMMATION; NEUTROPHILS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 80051926241     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.08.002     Document Type: Review

References (86)

1. Jennette, J.C., Falk, R.J., Small-vessel vasculitis. N Engl J Med 337 (1997), 1512–1523.
2. Falk, R.J., Gross, W.L., Guillevin, L., Hoffman, G.S., Jayne, D.R., Jennette, J.C., et al., American College of Rheumatology, American Society of Nephrology, European League Against Rheumatism. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum 63 (2011), 863–864.
3. Jennette, J.C., Falk, R.J., Andrassy, K., Bacon, P.A., Churg, J., Gross, W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 (1994), 187–192.
4. Kallenberg, C.G., Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 70:Suppl 1 (2011), i59–i63.
5. van der Woude, F.J., Rasmussen, N., Lobatto, S., Wiik, A., Permin, H., van Es, L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1 (1985), 425–429.
6. Falk, R.J., Jennette, J.C., Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318 (1988), 1651–1657.
7. Niles, J.L., McCluskey, R.T., Ahmad, M.F., Arnaout, M.A., Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74 (1989), 1888–1893.
8. Lochman, I., Kral, V., Lochmanova, A., Lupac, J., Cebecauer, L., ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmun Rev 10 (2011), 295–298.
9. Harper, L., Cockwell, P., Adu, D., Savage, C.O., Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int 59 (2001), 1729–1738.
10. Kallenberg, C.G., Heeringa, P., Stegeman, C.A., Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2 (2006), 661–670.
11. Brouwer, E., Huitema, M.G., Mulder, A.H., Heeringa, P., van Goor, H., Tervaert, J.W., et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 45 (1994), 1120–1131.
12. Hu, N., Westra, J., Kallenberg, C.G., Dysregulated neutrophil–endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention. Autoimmun Rev 10 (2011), 536–543.
13. Muller Kobold, A.C., Kallenberg, C.G., Tervaert, J.W., Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 58 (1999), 237–245.
14. Wikman, A., Fagergren, A., Forslid, J., Jacobson, S.H., Johansson, S.G., Lundahl, J., Antineutrophil cytoplasmic antibodies induce decreased CD62L expression and enhanced metabolic activity in monocytes. Scand J Immunol 57 (2003), 179–184.
15. Mackiewicz, Z., Rimkevicius, A., Petersen, J., Andersen, C.B., Dudek, E., Vytrasova, M., et al. Macrophages overloaded with tissue debris in Wegener's granulomatosis. Ann Rheum Dis 64 (2005), 1229–1232.
16. Bansal, P.J., Tobin, M.C., Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93 (2004), 398–401.
17. Jones, R.B., Tervaert, J.W., Hauser, T., Luqmani, R., Morgan, M.D., Peh, C.A., et al., European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363 (2010), 211–220.
18. Stone, J.H., Merkel, P.A., Spiera, R., Seo, P., Langford, C.A., Hoffman, G.S., et al., RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363 (2010), 221–232.
19. Pons-Estel, G.J., Salerni, G.E., Serrano, R.M., Gomez-Puerta, J.A., Plasin, M.A., Aldasoro, E., et al. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. Autoimmun Rev, 2011, 10.1016/j.autrev.2011.04.028.
20. Heeringa, P., Little, M.A., In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitations. Arthritis Res Ther, 13, 2011, 204.
21. Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002), 955–963.
22. Little, M.A., Al-Ani, B., Ren, S., Al-Nuaimi, H., Alpers, C.E., Savage, C., et al. Human anti-PR3 ANCA recapitulate systemic vasculitis in mice with a humanized immune system. Clin Exp Immunol, 164, 2011, 124 (Abstract).
23. Stegeman, C.A., Tervaert, J.W., Sluiter, W.J., Manson, W.L., de Jong, P.E., Kallenberg, C.G., Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120 (1994), 12–17.
24. Stegeman, C.A., Tervaert, J.W., de Jong, P.E., Kallenberg, C.G., Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 335 (1996), 16–20.
25. Pendergraft, W.F. III, Preston, G.A., Shah, R.R., Tropsha, A., Carter, C.W. Jr., Jennette, J.C., et al. Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3. Nat Med 10 (2004), 72–79.
26. Preston, G., Falk, R., Autoimmunity: does autoantigen complementarity underlie PR3-ANCA AAV?. Nat Rev Rheumatol 7 (2011), 439–440.
27. Tadema, H., Kallenberg, C.G., Stegeman, C.A., Heeringa, P., Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One, 6, 2011, e17972.
28. Cui, Z., Zhao, M.H., Segelmark, M., Hellmark, T., Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 78 (2010), 590–597.
29. Xu, P.C., Cui, Z., Chen, M., Hellmark, T., Zhao, M.H., Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford) 50 (2011), 1236–1243.
30. Wilde, B., Thewissen, M., Damoiseaux, J., van Paassen, P., Witzke, O., Tervaert, J.W., T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?. Arthritis Res Ther, 12, 2010, 204.
31. D'Cruz, D., Direskeneli, H., Khamashta, M., Hughes, G.R., Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity. J Rheumatol 26 (1999), 103–109.
32. Sanders, J.S., Huitma, M.G., Kallenberg, C.G., Stegeman, C.A., Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 65 (2006), 1484–1489.
33. Brouwer, E., Stegeman, C.A., Huitema, M.G., Limburg, P.C., Kallenberg, C.G., T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 98 (1994), 448–453.
34. Seta, N., Kobayashi, S., Hashimoto, H., Kuwana, M., Characterization of autoreactive T-cell clones to myeloperoxidase in patients with microscopic polyangiitis and healthy individuals. Clin Exp Rheumatol 27 (2009), 826–829.
35. de Menthon, M., Lambert, M., Guiard, E., Tognarelli, S., Bienvenu, B., Karras, A., et al. Excessive interleukin-15 transpresentation endows NKG2D + CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's). Arthritis Rheum 63 (2011), 2116–2126.
36. Caruso, A.M., Serbina, N., Klein, E., Triebold, K., Bloom, B.R., Flynn, J.L., Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 162 (1999), 5407–5416.
37. Di Perri, G., Cazzadori, A., Vento, S., Bonora, S., Malena, M., Bontempini, L., et al. Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients, Tuber. Lung Dis 77 (1996), 244–249.
38. Abdulahad, W.H., van der Geld, Y.M., Stegeman, C.A., Kallenberg, C.G., Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 70 (2006), 938–947.
39. Lamprecht, P., Erdmann, A., Mueller, A., Csernok, E., Reinhold-Keller, E., Holl-Ulrich, K., et al. Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis. Arthritis Res Ther 5 (2003), R25–R31.
40. Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999), 708–712.
41. Pepper, M., Jenkins, M.K., Origins of CD4(+) effector and central memory T cells. Nat Immunol 12 (2011), 467–471.
42. Abdulahad, W.H., Kallenberg, C.G., Limburg, P.C., Stegeman, C.A., Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 60 (2009), 2830–2838.
43. Capraru, D., Muller, A., Csernok, E., Gross, W.L., Holl-Ulrich, K., Northfield, J., et al. Expansion of circulating NKG2D + effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin Immunol 127 (2008), 144–150.
44. Tanriver, Y., Martin-Fontecha, A., Ratnasothy, K., Lombardi, G., Lechler, R., Superantigen-activated regulatory T cells inhibit the migration of innate immune cells and the differentiation of naive T cells. J Immunol 183 (2009), 2946–2956.
45. Enarsson, K., Lundin, B.S., Johnsson, E., Brezicka, T., Quiding-Jarbrink, M., CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur J Immunol 37 (2007), 282–291.
46. Fazilleau, N., Mark, L., McHeyzer-Williams, L.J., McHeyzer-Williams, M.G., Follicular helper T cells: lineage and location. Immunity 30 (2009), 324–335.
47. Csernok, E., Trabandt, A., Muller, A., Wang, G.C., Moosig, F., Paulsen, J., et al. Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 42 (1999), 742–750.
48. Nogueira, E., Hamour, S., Sawant, D., Henderson, S., Mansfield, N., Chavele, K.M., et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 25 (2010), 2209–2217.
49. Ooi, J.D., Kitching, A.R., Holdsworth, S.R., Review: T helper 17 cells: their role in glomerulonephritis. Nephrology (Carlton) 15 (2010), 513–521.
50. Abdulahad, W.H., Stegeman, C.A., Limburg, P.C., Kallenberg, C.G., Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 58 (2008), 2196–2205.
51. Ivanov, S., Bozinovski, S., Bossios, A., Valadi, H., Vlahos, R., Malmhall, C., et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am J Respir Cell Mol Biol 36 (2007), 442–451.
52. Jovanovic, D.V., Di Battista, J.A., Martel-Pelletier, J., Jolicoeur, F.C., He, Y., Zhang, M., et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160 (1998), 3513–3521.
53. Gan, P.Y., Steinmetz, O.M., Tan, D.S., O'Sullivan, K.M., Ooi, J.D., Iwakura, Y., et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 21 (2010), 925–931.
54. Hoshino, A., Nagao, T., Nagi-Miura, N., Ohno, N., Yasuhara, M., Yamamoto, K., et al. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J Autoimmun 31 (2008), 79–89.
55. Crispin, J.C., Tsokos, G.C., Interleukin-17-producing T cells in lupus. Curr Opin Rheumatol 22 (2010), 499–503.
56. Fletcher, J.M., Lonergan, R., Costelloe, L., Kinsella, K., Moran, B., O'Farrelly, C., et al. CD39 + Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 183 (2009), 7602–7610.
57. Abdulahad, W.H., Stegeman, C.A., van der Geld, Y.M., Doornbos-van der Meer, B., Limburg, P.C., Kallenberg, C.G., Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 56 (2007), 2080–2091.
58. Morgan, M.D., Day, C.J., Piper, K.P., Khan, N., Harper, L., Moss, P.A., et al. Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology 130 (2010), 64–73.
59. Rimbert, M., Hamidou, M., Braudeau, C., Puechal, X., Teixeira, L., Caillon, H., et al. Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One, 6, 2011, e18734.
60. Afzali, B., Mitchell, P., Lechler, R.I., John, S., Lombardi, G., Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 159 (2010), 120–130.
61. Abdulahad, W.H., Boots, A.M., Kallenberg, C.G., FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells. Rheumatology (Oxford) 50 (2011), 646–656.
62. Noronha, I.L., Kruger, C., Andrassy, K., Ritz, E., Waldherr, R., In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43 (1993), 682–692.
63. Kramer, J.A., Muller, A., Herlyn, K., Pitann, S., Lamprecht, P., Holl-Ulrich, K., et al. B lymphocyte differentiation in granulomatous tissues of the lung and the nasal mucosa in Wegener's granulomatosis: origin of anti-neutrophil cytoplasmic antibody formation?. Z Rheumatol 66 (2007), 421–429.
64. Hsu, H.C., Yang, P., Wang, J., Wu, Q., Myers, R., Chen, J., et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9 (2008), 166–175.
65. Crotty, S., Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29 (2011), 621–663.
66. Simpson, N., Gatenby, P.A., Wilson, A., Malik, S., Fulcher, D.A., Tangye, S.G., et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 62 (2010), 234–244.
67. fh) in patients with WG. Clin Exp Immunol, 164, 2011, 149 (Abstract).
68. Khan, A., Lawson, C.A., Quinn, M.A., Isdale, A.H., Green, M.J., Successful treatment of ANCA-negative Wegener's granulomatosis with rituximab. Int J Rheumatol, 2010, 2010, 846063.
69. Lund, F.E., Randall, T.D., Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol 10 (2010), 236–247.
70. Culton, D.A., Nicholas, M.W., Bunch, D.O., Zhen, Q.L., Kepler, T.B., Dooley, M.A., et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 27 (2007), 53–68.
71. Steinmetz, O.M., Velden, J., Kneissler, U., Marx, M., Klein, A., Helmchen, U., et al. Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int 74 (2008), 448–457.
72. Schneeweis, C., Rafalowicz, M., Feist, E., Buttgereit, F., Rudolph, P.E., Burmester, G.R., et al. Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV). Clin Exp Rheumatol 28 (2010), 62–66.
73. Mackay, F., Schneider, P., Cracking the BAFF code. Nat Rev Immunol 9 (2009), 491–502.
74. Nagai, M., Hirayama, K., Ebihara, I., Shimohata, H., Kobayashi, M., Koyama, A., Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity. Nephron Clin Pract 118 (2011), c339–c345.
75. Bader, L., Koldingsnes, W., Nossent, J., B-lymphocyte activating factor levels are increased in patients with Wegener's granulomatosis and inversely correlated with ANCA titer. Clin Rheumatol 29 (2010), 1031–1035.
76. Holden, N.J., Williams, J.M., Harper, L., Gordon, J., Savage, C.O., ANCA-stimulated neutrophils release BLyS and promote B cell survival in vitro. Clin Exp Immunol, 164, 2011, 137 (Abstract).
77. Katz, S.I., Parker, D., Turk, J.L., B-cell suppression of delayed hypersensitivity reactions. Nature 251 (1974), 550–551.
78. Wolf, S.D., Dittel, B.N., Hardardottir, F., Janeway, C.A. Jr., Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184 (1996), 2271–2278.
79. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D., Anderton, S.M., B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3 (2002), 944–950.
80. Blair, P.A., Norena, L.Y., Flores-Borja, F., Rawlings, D.J., Isenberg, D.A., Ehrenstein, M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32 (2010), 129–140.
81. Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D.J., Yanaba, K., Venturi, G.M., et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117 (2011), 530–541.
82. Mauri, C., Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 22 (2010), 761–767.
83. Bouaziz, J.D., Calbo, S., Maho-Vaillant, M., Saussine, A., Bagot, M., Bensussan, A., et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 40 (2010), 2686–2691.
84. Carter, N.A., Vasconcellos, R., Rosser, E.C., Tulone, C., Munoz-Suano, A., Kamanaka, M., et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 186 (2011), 5569–5579.
85. Chaudhry, A., Samstein, R.M., Treuting, P., Liang, Y., Pils, M.C., Heinrich, J.M., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34 (2011), 566–578.
86. Hruskova, Z., Rihova, Z., Mareckova, H., Jancova, E., Rysava, R., Zavada, J., et al. Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up. Arch Med Res 40 (2009), 276–284.